COVID19 Update: For your safety, you will be asked to use a mask, if you do not have one, a mask will be provided. If a person presents with a temperature, you will be asked to return home and further instructions will be given by your health care team. For our patients protection, no visitors under 18 will be allowed in the offices, there is a limit one (1) visitor per patient if necessary. No visitors are allowed in the chemo infusion room. Telemedicine are available for routine office visits. More Information-PLEASE CLICK HERE

Clinical Trial: 17 058

Trial Status: Open
Trial Type: Brain
Disease Type: Brain
Trial ID 17 058
Sponsor ID

A Randomized, Multicenter, Phase 2 Study of DSP-7888 Dosing Emulsion in Combination with Bevacizumab versus Bevacizumab Alone in Patients with Recurrent or Progressive Glioblastoma following Initial Therapy (BBI-DSP7888-201G)

Principal Investigator
Dipti Patel-Donnelly, MD
3 Locations


Fairfax Office

Arlington Infusion Suite

Gainesville Office

Learn More About This Trial
Other Relevant Trials